BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/21/2022 9:21:57 AM | Browse: 21 | Download: 15
Publication Name World Journal of Clinical Oncology
Manuscript ID 80966
Country/Territory Australia
Received
2022-10-19 10:06
Peer-Review Started
2022-10-19 10:08
To Make the First Decision
Return for Revision
2022-10-28 09:20
Revised
2022-10-30 11:08
Second Decision
2022-11-07 03:26
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-11-07 18:13
Articles in Press
2022-11-07 18:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-11-16 06:38
Publish the Manuscript Online
2022-11-21 04:25
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Systematic Reviews
Article Title Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
Manuscript Source Invited Manuscript
All Author List Oliver Oey, Yu-Yang Liu, Angela Felicia Sunjaya, Daniel Martin Simadibrata, Muhammad Adnan Khattak and Elin Gray
Funding Agency and Grant Number
Corresponding Author Oliver Oey, MD, Doctor, Researcher, Department of Internal Medicine, St John of God Midland Public and Private Hospital, Midland, No. 1 Clayton Street, Perth 6004, WA, Australia. oliver.oey@sjog.org.au
Key Words Melanoma; Gut microbiome; Microbiota; Immunotherapy; Biomarker; Immune checkpoint blockade therapy
Core Tip Since the introduction of immune checkpoint inhibitors as part of standard of care for melanoma patients, there has been a growing interest in identifying biomarkers of response and immune related adverse events. Amongst these biomarkers, the composition of the gut microbiome has been one of the most intriguing discoveries. Our aim was to ascertain the current published evidence on the gut microbiome diversity and composition as a biomarker of response to immunotherapy. We demonstrated high variability in the results and limited concordance on the organisms identified. We highlight the conflicting aspects of these reports as well as their few commonalities.
Publish Date 2022-11-21 04:25
Citation Oey O, Liu YY, Sunjaya AF, Simadibrata DM, Khattak MA, Gray E. Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review. World J Clin Oncol 2022; 13(11): 929-942
URL https://www.wjgnet.com/2218-4333/full/v12/i11/929.htm
DOI https://dx.doi.org/10.5306/wjco.v13.i11.929
Full Article (PDF) WJCO-13-929.pdf
Full Article (Word) WJCO-13-929.docx
Manuscript File 80966_Auto_Edited-LM.docx
Answering Reviewers 80966-Answering reviewers.pdf
Audio Core Tip 80966-Audio core tip.m4a
Biostatistics Review Certificate 80966-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 80966-Conflict-of-interest statement.pdf
Copyright License Agreement 80966-Copyright license agreement.pdf
Peer-review Report 80966-Peer-review(s).pdf
Scientific Misconduct Check 80966-Bing-Wang LL-2.png
Scientific Editor Work List 80966-Scientific editor work list.pdf